Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
TOLEVAMER POTASSIUM SODIUM
(3)
Small molecule
Toxin A binding agent
Unknown
Investigational
Unknown
TOLEVAMER POTASSIUM SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
4A5OM7PI18
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
25-HYDROXYERGOCALCIFEROL-
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
25-HYDROXYERGOCALCIFEROL-
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NERAMEXANE MESYLATE
(3)
Small molecule
Glutamate [NMDA] receptor antagonist
Unknown
Investigational
Unknown
NERAMEXANE MESYLATE
×
Maximum Phase:
3
First Approval:
None
UNII:
9M85GXG84D
Molecule Type:
Small molecule
Molecular Formula:
C12H27NO3S
Molecular Weight:
265.42
AlogP:
2.94
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
0.0
Source:
SERINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
SERINE
×
Maximum Phase:
3
First Approval:
None
UNII:
452VLY9402
Molecule Type:
Small molecule
Molecular Formula:
C3H7NO3
Molecular Weight:
105.09
AlogP:
-1.61
PSA:
83.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
FAVIPIRAVIR
(3)
Small molecule
RNA-directed RNA polymerase inhibitor
Unknown
Investigational
Unknown
FAVIPIRAVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
EW5GL2X7E0
Molecule Type:
Small molecule
Molecular Formula:
C5H4FN3O2
Molecular Weight:
157.1
AlogP:
-0.58
PSA:
89.1
HBD:
2.0
HBA:
#RotB:
1.0
Source:
COMFILCON A
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
COMFILCON A
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESFLURBIPROFEN
(3)
Small molecule
Cyclooxygenase inhibitor
Unknown
Investigational
Unknown
ESFLURBIPROFEN
×
Maximum Phase:
3
First Approval:
None
UNII:
J5ZZK9P7MX
Molecule Type:
Small molecule
Molecular Formula:
C15H13FO2
Molecular Weight:
244.26
AlogP:
3.68
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
3.0
Source:
M3
(3)
Antibody
Unknown
Unknown
Metabolites
Unknown
M3
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZIRITAXESTAT
(3)
Small molecule
Autotaxin inhibitor
Unknown
Investigational
Unknown
ZIRITAXESTAT
×
Maximum Phase:
3
First Approval:
None
UNII:
I02418V13W
Molecule Type:
Small molecule
Molecular Formula:
C30H33FN8O2S
Molecular Weight:
588.71
AlogP:
3.43
PSA:
104.24
HBD:
1.0
HBA:
#RotB:
7.0
Source:
GOVORESTAT
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
GOVORESTAT
×
Maximum Phase:
3
First Approval:
None
UNII:
6JLQ8K35KK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F3N3O3S2
Molecular Weight:
425.41
AlogP:
3.76
PSA:
85.08
HBD:
1.0
HBA:
#RotB:
4.0
Source:
VICRIVIROC MALEATE
(3)
Small molecule
C-C chemokine receptor type 5 antagonist
Unknown
Investigational
Unknown
VICRIVIROC MALEATE
×
Maximum Phase:
3
First Approval:
None
UNII:
EP3QG127N9
Molecule Type:
Small molecule
Molecular Formula:
C32H42F3N5O6
Molecular Weight:
649.71
AlogP:
4.5
PSA:
61.8
HBD:
0.0
HBA:
#RotB:
6.0
Source:
AMRUBICIN
(3)
Small molecule
DNA topoisomerase II alpha inhibitor
Unknown
Investigational
Unknown
AMRUBICIN
×
Maximum Phase:
3
First Approval:
None
UNII:
93N13LB4Z2
Molecule Type:
Small molecule
Molecular Formula:
C25H25NO9
Molecular Weight:
483.47
AlogP:
0.63
PSA:
176.61
HBD:
5.0
HBA:
#RotB:
3.0
Source:
UBIDECARENONE
(3)
Small molecule
Supplement
Unknown
Investigational
Unknown
UBIDECARENONE
×
Maximum Phase:
3
First Approval:
None
UNII:
EJ27X76M46
Molecule Type:
Small molecule
Molecular Formula:
C59H90O4
Molecular Weight:
863.36
AlogP:
17.85
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
31.0
Source:
RILMENIDINE
(3)
Small molecule
Nischarin agonist
Unknown
Approved
Unknown
RILMENIDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
P67IM25ID8
Molecule Type:
Small molecule
Molecular Formula:
C10H16N2O
Molecular Weight:
180.25
AlogP:
1.15
PSA:
33.62
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TALAPORFIN SODIUM
(3)
Small molecule
Photosensitizing agent
Unknown
Investigational
Unknown
TALAPORFIN SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
L63605PZ70
Molecule Type:
Small molecule
Molecular Formula:
C38H37N5Na4O9
Molecular Weight:
799.7
AlogP:
5.95
PSA:
235.66
HBD:
7.0
HBA:
#RotB:
12.0
Source:
VADIMEZAN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
VADIMEZAN
×
Maximum Phase:
3
First Approval:
None
UNII:
0829J8133H
Molecule Type:
Small molecule
Molecular Formula:
C17H14O4
Molecular Weight:
282.3
AlogP:
3.19
PSA:
67.51
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FALDAPREVIR
(3)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Unknown
Investigational
Unknown
FALDAPREVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
958X4J301A
Molecule Type:
Small molecule
Molecular Formula:
C40H49BrN6O9S
Molecular Weight:
869.84
AlogP:
6.3
PSA:
198.38
HBD:
4.0
HBA:
#RotB:
13.0
Source:
TAVAPADON
(3)
Small molecule
Dopamine D1 receptor partial agonist
Unknown
Investigational
Unknown
TAVAPADON
×
Maximum Phase:
3
First Approval:
None
UNII:
PT4P8MJP8L
Molecule Type:
Small molecule
Molecular Formula:
C19H16F3N3O3
Molecular Weight:
391.35
AlogP:
3.56
PSA:
76.98
HBD:
1.0
HBA:
#RotB:
3.0
Source:
FOLITIXORIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
FOLITIXORIN
×
Maximum Phase:
3
First Approval:
None
UNII:
0SXY5ET48B
Molecule Type:
Small molecule
Molecular Formula:
C20H23N7O6
Molecular Weight:
457.45
AlogP:
-0.52
PSA:
193.98
HBD:
6.0
HBA:
#RotB:
7.0
Source:
RAC-3-N-BUTYLPHTHALIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
RAC-3-N-BUTYLPHTHALIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
822Q956KGM
Molecule Type:
Small molecule
Molecular Formula:
C12H14O2
Molecular Weight:
190.24
AlogP:
3.09
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
3.0
Source:
DELEOBUVIR
(3)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
DELEOBUVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
58BU988K90
Molecule Type:
Small molecule
Molecular Formula:
C34H33BrN6O3
Molecular Weight:
653.58
AlogP:
6.85
PSA:
114.93
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ARTEMISIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ARTEMISIN
×
Maximum Phase:
3
First Approval:
None
UNII:
Y1R67R7XWU
Molecule Type:
Small molecule
Molecular Formula:
C15H22O5
Molecular Weight:
282.34
AlogP:
2.39
PSA:
53.99
HBD:
0.0
HBA:
#RotB:
0.0
Source:
RIVOGLITAZONE
(3)
Small molecule
Peroxisome proliferator-activated receptor gamma agonist
Unknown
Investigational
Unknown
RIVOGLITAZONE
×
Maximum Phase:
3
First Approval:
None
UNII:
3A3N0634Q6
Molecule Type:
Small molecule
Molecular Formula:
C20H19N3O4S
Molecular Weight:
397.46
AlogP:
3.06
PSA:
82.45
HBD:
1.0
HBA:
#RotB:
6.0
Source:
MK-0557
(3)
Small molecule
Neuropeptide Y receptor type 5 antagonist
Unknown
Investigational
Unknown
MK-0557
×
Maximum Phase:
3
First Approval:
None
UNII:
HVE36P8422
Molecule Type:
Small molecule
Molecular Formula:
C22H19FN4O3
Molecular Weight:
406.42
AlogP:
3.6
PSA:
86.11
HBD:
1.0
HBA:
#RotB:
3.0
Source:
IMIGLITAZAR
(3)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
Unknown
Investigational
Unknown
IMIGLITAZAR
×
Maximum Phase:
3
First Approval:
None
UNII:
7244710F59
Molecule Type:
Small molecule
Molecular Formula:
C28H26N2O5
Molecular Weight:
470.53
AlogP:
6.01
PSA:
94.15
HBD:
1.0
HBA:
#RotB:
11.0
Source:
TAGATOSE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TAGATOSE
×
Maximum Phase:
3
First Approval:
None
UNII:
T7A20Y888Y
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.38
PSA:
118.22
HBD:
5.0
HBA:
#RotB:
5.0
Source:
PREGNENOLONE SUCCINATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
PREGNENOLONE SUCCINATE
×
Maximum Phase:
3
First Approval:
None
UNII:
6LN4W6JJK6
Molecule Type:
Small molecule
Molecular Formula:
C25H36O5
Molecular Weight:
416.56
AlogP:
4.93
PSA:
80.67
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ALTROPANE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALTROPANE
×
Maximum Phase:
3
First Approval:
None
UNII:
1Q4092099O
Molecule Type:
Small molecule
Molecular Formula:
C18H21FINO2
Molecular Weight:
429.27
AlogP:
3.88
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
4.0
Source:
VALILTRAMIPROSATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
VALILTRAMIPROSATE
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GALACTOSE
(3)
Small molecule
Unknown
Unknown
Approved
Unknown
GALACTOSE
×
Maximum Phase:
3
First Approval:
None
UNII:
X2RN3Q8DNE
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
IPRAGLIFLOZIN L-PROLINE
(3)
Small molecule
Sodium/glucose cotransporter 2 inhibitor
Unknown
Investigational
Unknown
IPRAGLIFLOZIN L-PROLINE
×
Maximum Phase:
3
First Approval:
None
UNII:
M6N3GK48A4
Molecule Type:
Small molecule
Molecular Formula:
C26H30FNO7S
Molecular Weight:
519.59
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RIGOSERTIB
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
RIGOSERTIB
×
Maximum Phase:
3
First Approval:
None
UNII:
67DOW7F9GL
Molecule Type:
Small molecule
Molecular Formula:
C21H25NO8S
Molecular Weight:
451.5
AlogP:
2.8
PSA:
120.39
HBD:
2.0
HBA:
#RotB:
11.0
Source:
ELOBIXIBAT
(3)
Small molecule
Ileal bile acid transporter inhibitor
Unknown
Investigational
Unknown
ELOBIXIBAT
×
Maximum Phase:
3
First Approval:
None
UNII:
865UEK4EJC
Molecule Type:
Small molecule
Molecular Formula:
C36H45N3O7S2
Molecular Weight:
695.9
AlogP:
6.14
PSA:
142.11
HBD:
3.0
HBA:
#RotB:
16.0
Source:
PELUBIPROFEN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
PELUBIPROFEN
×
Maximum Phase:
3
First Approval:
None
UNII:
1619C79FVJ
Molecule Type:
Small molecule
Molecular Formula:
C16H18O3
Molecular Weight:
258.32
AlogP:
3.4
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
3.0
Source:
APLAVIROC HYDROCHLORIDE
(3)
Small molecule
C-C chemokine receptor type 5 antagonist
Unknown
Investigational
Unknown
APLAVIROC HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
04D148Z3VR
Molecule Type:
Small molecule
Molecular Formula:
C33H44ClN3O6
Molecular Weight:
614.18
AlogP:
4.58
PSA:
119.41
HBD:
3.0
HBA:
#RotB:
10.0
Source:
TARIBAVIRIN HYDROCHLORIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TARIBAVIRIN HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
D22JZE246P
Molecule Type:
Small molecule
Molecular Formula:
C8H14ClN5O4
Molecular Weight:
279.68
AlogP:
-2.83
PSA:
150.5
HBD:
5.0
HBA:
#RotB:
3.0
Source:
1
2
…
178
179
180
181
182
183
184
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA